Faes Farma (0K9H) Stock Statistics & Valuation Metrics
Total Valuation
Faes Farma has a market cap or net worth of EUR 1.50B. The enterprise value is EUR 1.70B.
- Market Cap
- EUR 1.50B
- Enterprise Value
- EUR 1.70B
Share Statistics
Faes Farma has 316,223,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 316,223,940
- Owned by Insiders
- 1.29%
- Owned by Institutions
- 2.96%
Financial Efficiency
Faes Farma’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.71%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 5.71%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 228.04K
- Profits Per Employee
- 29.75K
- Employee Count
- 2,677
- Asset Turnover
- 0.45
- Inventory Turnover
- 2.06
Valuation Ratios
The current PE Ratio of Faes Farma is 11.10. Faes Farma’s PEG ratio is 2.27.
- PE Ratio
- 11.10
- PS Ratio
- 1.44
- PB Ratio
- 1.94
- Price to FCF
- 24.38
- Price to Operating Cash Flow
- 18.90
- PEG Ratio
- 2.27
Income Statement
In the last 12 months, Faes Farma had revenue of 610.46M and earned 79.63M in profits. Earnings per share was 0.26.
- Revenue
- 610.46M
- Gross Profit
- 228.46M
- Operating Income
- 72.76M
- Pretax Income
- 85.41M
- Net Income
- 79.63M
- EBITDA
- 101.80M
- Earnings Per Share (EPS)
- 0.26
Cash Flow
In the last 12 months, operating cash flow was 79.45M and capital expenditures -17.82M, giving a free cash flow of 61.63M billion.
- Operating Cash Flow
- 79.45M
- Free Cash Flow
- 61.63M
- Free Cash Flow per Share
- 0.20
Dividends & Yields
Faes Farma pays an annual dividend of ―, resulting in a dividend yield of 2.63%
- Dividend Per Share
- ―
- Dividend Yield
- 2.63%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.10%
- Earnings Yield
- 9.07%
Stock Price Statistics
- Beta
- 0.51
- 52-Week Price Change
- 8.70%
- 50-Day Moving Average
- 4.65
- 200-Day Moving Average
- 4.66
- Relative Strength Index (RSI)
- 57.36
- Average Volume (3m)
- 17.28K
Important Dates
Faes Farma upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Faes Farma as a current ratio of 2.61, with Debt / Equity ratio of 55.04%
- Current Ratio
- 2.61
- Quick Ratio
- 1.61
- Debt to Market Cap
- 0.25
- Net Debt to EBITDA
- 2.87
- Interest Coverage Ratio
- 11.51
Taxes
In the past 12 months, Faes Farma has paid 5.75M in taxes.
- Income Tax
- 5.75M
- Effective Tax Rate
- 0.07
Enterprise Valuation
Faes Farma EV to EBITDA ratio is 10.59, with an EV/FCF ratio of 28.82.
- EV to Sales
- 1.70
- EV to EBITDA
- 10.59
- EV to Free Cash Flow
- 28.82
- EV to Operating Cash Flow
- 22.35
Balance Sheet
Faes Farma has EUR 136.78M in cash and marketable securities with EUR 396.85M in debt, giving a net cash position of -EUR 260.07M billion.
- Cash & Marketable Securities
- EUR 136.78M
- Total Debt
- EUR 396.85M
- Net Cash
- -EUR 260.07M
- Net Cash Per Share
- -EUR 0.82
- Tangible Book Value Per Share
- EUR 0.82
Margins
Gross margin is 29.90%, with operating margin of 24.55%, and net profit margin of 13.05%.
- Gross Margin
- 29.90%
- Operating Margin
- 24.55%
- Pretax Margin
- 14.58%
- Net Profit Margin
- 13.05%
- EBITDA Margin
- 16.06%
- EBIT Margin
- 11.54%
Analyst Forecast
The average price target for Faes Farma is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 31.88%
- EPS Growth Forecast
- -20.09%
Scores
- Smart Score
- 5
- AI Score
- ―
